Progestin-only implant and breast cancer risk in adolescents and premenopausal women: A systematic review and meta-analysis
Cancer Epidemiology · 2026-08 · 103 · 103122
DOI: 10.1016/j.canep.2026.103122 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Cancer Epidemiology, 2026-08. Verfasst von Angela Theresa Zuffo Yabrude und 5 weiteren Autor:innen. Beteiligte Einrichtung: Universidade Regional de Blumenau (FURB), Blumenau, Brazil. Electronic address: zuffoa28@gmail.com. Hauptthemen laut MEDLINE: Breast Neoplasms, Progestins, Drug Implants. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 15 Literaturangaben.
Abstract (Originalsprache)
Long-acting reversible contraception with progestin-only subdermal implants is widely adopted. However, the breast cancer (BC) risk signal attributable to implants remains under-characterized, limiting evidence-based counseling. We systematically searched PubMed/MEDLINE, Embase, and Scopus,and screened references for observational cohort and case-control studies evaluating progestin-only implant versus non-use hormonal contraception in adolescents and premenopausal women without prior BC. The primary endpoint was incident BC (invasive with/without in situ, per study definition). Maximally adjusted effect estimates were extracted; measures were harmonized to odds ratios (ORs). Risk of bias was assessed with ROBINS-E. Pooled estimates used inverse-variance random-effects meta-analysis; heterogeneity was quantified with I² and Tau². Five studies met inclusion criteria (3 nationwide cohorts from Denmark/Sweden and 2 nested case-control studies from the UK and Australia). Across cohort studies, implant exposure accounted for 1659,309 person-years with 510 BC events. The largest case-control dataset included 67,470 BC cases. Study-specific adjusted estimates were: Morch 2017 RR 0.93 (95% CI 0.48-1.80), Fitzpatrick 2023 OR 1.22 (0.93-1.60), Hadizadeh 2025 HR 1.22 (1.11-1.35), Hultstrand 2022 IRR 1.22 (0.98-1.52), and Tuesley 2025 OR 1.24 (1.17-1.32). The pooled effect showed higher incident BC risk with implant exposure (OR 1.23, 95% CI 1.19-1.27, p < 0.0001) with no observed heterogeneity (I²=0%; Tau²=0). In contemporary population-based data, progestin-only subdermal implant use is associated with a modest but statistically increase (∼23%) in incident BC risk versus non-use. Given low baseline incidence in younger women, absolute risk impact is likely small, but the signal is decision-relevant for shared contraceptive counseling, particularly in patients with elevated baseline BC risk.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Universidade Regional de Blumenau (FURB), Blumenau, Brazil. Electronic address: zuffoa28@gmail.com.
- University of São Paulo (USP), São Paulo, Brazil.
- Universidad Hispanoamericana, San José, Costa Rica.
- Instituto Nacional do Câncer (INCA), Rio de Janeiro, Brazil.
- Università degli Studi di Bari, Bari, Italy.
- Unimed Sorocaba, Sorocaba, Brazil.
Zitieren
APA
Yabrude, A. T. Z., Reis, L. C. S., Anchía, A. J. R., Dos Santos, T. A. E., de Albuquerque, C. F. A., & Del Fiol Manna, E. (2026). Progestin-only implant and breast cancer risk in adolescents and premenopausal women: A systematic review and meta-analysis. Cancer Epidemiology, 103, 103122. https://doi.org/10.1016/j.canep.2026.103122
Vancouver
Yabrude ATZ, Reis LCS, Anchía AJR, Dos Santos TAE, de Albuquerque CFA, Del Fiol Manna E. Progestin-only implant and breast cancer risk in adolescents and premenopausal women: A systematic review and meta-analysis. Cancer Epidemiology. 2026;103:103122. doi:10.1016/j.canep.2026.103122
BibTeX
@article{Yabrude2026,
author = {Yabrude, Angela Theresa Zuffo and Reis, Leila Caroline Souza and Anchía, Anthony Josué Rojas and Dos Santos, Thomás Alexandre Eugenio and de Albuquerque, Clara Fish Araújo and Del Fiol Manna, Eliza},
title = {Progestin-only implant and breast cancer risk in adolescents and premenopausal women: A systematic review and meta-analysis},
journal = {Cancer Epidemiology},
year = {2026},
volume = {103},
pages = {103122},
doi = {10.1016/j.canep.2026.103122}
}
EUVIMED